Interchangeability requires demonstrating that switching between the reference biologic and the biosimilar produces no greater safety or efficacy risk than remaining on the reference product
This SGLT2 Inhibitors resource gives broader class context, but your donor center still decides eligibility
CONTENT Posttest 1
Bruising, discomfort, and swelling are possible side effects for patients during the healing process
Get my baseline $99 Subscribe to our newsletter & join a community of 30,000+ Aussies Mounjaro (tirzepatide) is a prescription-only medicine approved in Australia for the treatment of type 2 diabetes, when prescribed and supervised by a medical professional
Zhang W, Konopleva M, Shi YX, McQueen T, Harris D, Ling X, Estrov Z, Quints-Cardama A, Small D, Cortes J, Andreeff M